Recombinant Deropeltis atra Periviscerokinin-1

What is the amino acid sequence of Deropeltis atra Periviscerokinin-1?

Periviscerokinin-1 has the general amino acid sequence Gly-Ser-Ser-Gly-Leu-Ile-Ala-Met-Pro-Arg-Val (GSSGLIAMPRV). This 11-amino acid peptide belongs to the broader family of CAPA peptides found across cockroach species, including Supella dimidiata, Supella longipalpa, Cryptocercus darwini, and Cryptocercus kyebangensis . While specific sequence variations may exist between species, this consensus sequence represents the core structure of PVK-1 peptides in cockroaches of the Dictyoptera order.

How does Periviscerokinin-1 differ structurally from other insect neuropeptides?

Periviscerokinin-1 belongs to the CAPA-periviscerokinins (PVKs) group, which are functionally and structurally distinct from other neuropeptide families. Unlike adipokinetic/hypertrehalosaemic hormones that show minimal sequence variations across insect species, PVKs demonstrate both conserved and variable regions that make them particularly valuable for phylogenetic analysis . The quantitative distribution of Periviscerokinin-1 differs considerably from other known insect neuropeptides, with over 90% of the total concentration localized in the abdominal ganglia and their perisympathetic organs, a pattern not observed with other neuropeptide families .

What are the most effective techniques for isolating native Periviscerokinin-1 from cockroach tissue?

For isolating native Periviscerokinin-1 from cockroach tissue, a multi-technique approach yields the best results. The protocol involves:

• Tissue extraction from abdominal perisympathetic organs (PSOs) and abdominal ganglia, where over 90% of the peptide is concentrated

• Initial separation using HPLC with specialized columns for neuropeptide isolation

• Immunological verification through ELISA using high-specificity antisera

• Final confirmation and sequencing via MALDI-TOF mass spectrometry

This integrated approach enables quantification of even small amounts of the peptide (in the picomolar range) with high specificity and minimal cross-reactivity with other insect neuropeptides.

How can mass spectrometry be optimized for accurate identification of Periviscerokinin-1 in complex tissue samples?

Tandem mass spectrometry techniques have revolutionized the identification of Periviscerokinin-1 in complex neuronal tissues. The optimized protocol includes:

• Direct tissue analysis using MALDI-TOF MS from single specimens

• Sample preparation modifications to minimize oxidation of the methionine residue, as Periviscerokinin-1 can appear in both oxidized and non-oxidized forms during HPLC separation

• Targeted analysis of abdominal perisympathetic organs where concentrated peptide exists

• Calibration using synthetic Periviscerokinin-1 standards to identify characteristic fragmentation patterns

• Data analysis focusing on the recognition of both the complete peptide and its diagnostic fragments

This approach permits unambiguous identification of CAPA peptides from single specimens without requiring extensive genomic approaches, which is particularly valuable for comparative studies across species .

What expression systems are most suitable for recombinant production of functional Deropeltis atra Periviscerokinin-1?

The optimal expression system for recombinant Periviscerokinin-1 production depends on research objectives, but several systems have demonstrated efficacy:

For functional studies requiring precise structural characteristics, insect cell expression systems more closely replicate the native peptide structure by preserving critical post-translational modifications that may affect receptor binding properties.

What strategies can minimize oxidation of the methionine residue in recombinant Periviscerokinin-1 during production and storage?

Methionine oxidation is a critical concern for Periviscerokinin-1, as demonstrated by the presence of both oxidized and non-oxidized forms in HPLC-separated tissue extracts . To minimize this issue:

• Include antioxidants (e.g., 0.1-0.5 mM methionine, 1-5 mM ascorbic acid) in purification buffers

• Maintain low pH (typically 3.0-4.0) during purification to reduce oxidation rates

• Perform all purification steps under nitrogen atmosphere when possible

• Store lyophilized peptide at or below -20°C with desiccant

• Add reducing agents (e.g., 1-5 mM DTT or TCEP) during experimental use if native structure is essential

These approaches significantly reduce methionine oxidation while maintaining peptide functionality for downstream applications.

How does Periviscerokinin-1 interact with its receptor, and what methods best characterize this interaction?

Periviscerokinin-1 binds to G-protein coupled receptors that are distinct from those that bind CAPA-pyrokinins, despite both being encoded by the same gene . Receptor interaction studies typically employ:

• Radioligand binding assays using labeled synthetic peptide

• Calcium flux measurements in receptor-expressing cell lines

• cAMP accumulation assays

• FRET/BRET-based interaction studies

• Computational molecular docking simulations

These approaches reveal that PVK-1 binding exhibits high specificity, with minimal cross-reactivity to other neuropeptide receptors, which explains the high conservation of these sequences through evolutionary time, making them valuable for phylogenetic analysis .

What is the neuroanatomical distribution of Periviscerokinin-1 in Dictyoptera species, and how does this inform functional studies?

Comprehensive neuroanatomical mapping reveals that Periviscerokinin-1 distribution follows a highly conserved pattern across Dictyoptera species, with important implications for functional studies:

• Highest concentrations (>90% of total) are found in abdominal ganglia and perisympathetic organs

• Quantitative analysis shows approximately 6.3 pmol in abdominal perisympathetic organs and 1.3 pmol in abdominal ganglia per animal (based on studies in Periplaneta americana)

• The brain, suboesophageal ganglion, metathoracic ganglion, and terminal ganglion contain detectable but significantly lower concentrations

• Notably, the corpora cardiaca and corpora allata lack immunoreactive material, suggesting that Periviscerokinin-1 is not released by the cephalic neurohemal system

This distinctive distribution pattern differs markedly from other neuropeptide families and provides critical guidance for designing targeted functional studies in specific neuronal tissues.

How can Periviscerokinin-1 sequence data be used for phylogenetic analysis of Dictyoptera species?

Periviscerokinin-1 and related CAPA peptides offer unique advantages for phylogenetic analysis of cockroaches and termites due to the following methodological considerations:

• The sequences contain both conserved regions (suitable for higher-level taxonomic relationships) and variable regions (informative for tip-level relationships between closely related species)

• Direct mass spectrometric screening of abdominal perisympathetic organs allows unambiguous identification of CAPA peptides from single specimens, enabling large-scale screening

• Analysis should employ both Maximum Parsimony and Bayesian Inference approaches to generate robust cladograms

• Combined datasets including other neuropeptide families (adipokinetic hormones, sulfakinins) can significantly increase bootstrap values in phylogenetic trees

This methodological approach has successfully reconstructed phylogenetic relationships that generally align with molecular and morphological analyses, including confirming the placement of termites within cockroaches .

What software tools and analytical parameters are most appropriate for constructing neuropeptide-based phylogenetic trees?

For effective phylogenetic analysis using Periviscerokinin-1 sequences, researchers should implement:

• Sequence alignment using MUSCLE or MAFFT with gap penalties optimized for short peptide sequences

• Maximum Parsimony analysis using PAUP* with 1,000+ bootstrap replicates

• Bayesian Inference using MrBayes with appropriate substitution models for peptide sequences

• Tree visualization with FigTree or iTOL for presenting evolutionary relationships

• Combined analysis with other CAPA peptides and neuropeptide families to enhance phylogenetic signal

When properly configured, these analytical tools produce cladograms with topologies that closely match those derived from conventional molecular markers, demonstrating the validity of neuropeptide sequences for phylogenetic reconstruction.

What controls and validation steps are essential when studying receptor activation by recombinant versus native Periviscerokinin-1?

Rigorous experimental design for comparative studies requires:

• Inclusion of both synthetic and native peptide preparations as positive controls

• Verification of peptide identity and purity via HPLC and mass spectrometry before receptor assays

• Testing for potential TFA (trifluoroacetic acid) contamination in synthetic peptides, as TFA residues can influence experimental data at nanomolar concentrations

• Dose-response curves covering concentrations from sub-nanomolar to micromolar range

• Confirmation of receptor specificity using competitive binding assays

• Negative controls using related but non-activating peptide sequences

These validation steps ensure that observed biological effects are specifically attributable to the peptide-receptor interaction rather than experimental artifacts.

How can researchers address the challenges of working with the methionine-containing sequence of Periviscerokinin-1 in functional studies?

The methionine residue in Periviscerokinin-1 (GSSGLIAMPRV) presents specific challenges that can be addressed through:

• Systematic comparison of native, oxidized, and non-oxidized forms of the peptide in functional assays

• Development of methionine-substituted analogs (e.g., norleucine replacement) that maintain receptor activation but resist oxidation

• Implementation of parallel assays with freshly prepared and aged peptide preparations to assess stability effects

• Use of reducing environments during functional assays when appropriate

• Careful monitoring of peptide oxidation state via analytical methods before and after experiments

Studies have identified two immunoreactive fractions in HPLC-separated tissue extracts corresponding to oxidized and non-oxidized forms of Periviscerokinin-1 , highlighting the importance of these considerations in experimental design.

How can recombinant Periviscerokinin-1 be utilized in neurophysiological research beyond traditional receptor binding studies?

Advanced neurophysiological applications of recombinant Periviscerokinin-1 include:

• Optogenetic coupling of receptor activation to study downstream signaling cascades

• Development of fluorescently labeled analogs for real-time imaging of peptide distribution and receptor dynamics

• Integration with electrophysiological recordings to assess effects on neuronal firing patterns

• Implementation in microfluidic organ-on-chip systems to study systemic effects

• Combination with CRISPR-based receptor modification to investigate structure-function relationships

These approaches extend beyond traditional binding studies to provide more integrated understanding of peptide function in complex neuronal networks.

What are the current hypotheses regarding the evolutionary conservation of Periviscerokinin-1 across Dictyoptera species?

Current evolutionary hypotheses propose that:

• The high degree of sequence conservation reflects strong functional constraints on receptor-ligand interactions

• The CAPA gene family underwent duplication events early in insect evolution, allowing diversification while maintaining core functional motifs

• Sequence conservation patterns align with the proposed monophyly of Mantodea and Isoptera within Dictyoptera

• Species-specific variations in flanking regions of the peptide reflect adaptations to different physiological requirements

• The distinct distribution pattern of Periviscerokinin-1 (>90% in abdominal ganglia) represents an ancient and evolutionarily stable neuroendocrine signaling system

These hypotheses are supported by phylogenetic analyses that show cladograms derived from CAPA peptide sequences largely agree with molecular and morphological data on Dictyoptera evolution .

What are common pitfalls in mass spectrometric analysis of Periviscerokinin-1, and how can they be avoided?

Common mass spectrometry challenges include:

• Methionine oxidation artifacts: Minimize by using reducing conditions during sample preparation and analyzing both oxidized and non-oxidized forms

• Signal suppression in complex samples: Address by employing appropriate sample fractionation before analysis

• Insufficient sensitivity for low-abundance peptides: Enhance by targeting specific tissues with high peptide concentration (abdominal PSOs)

• False identification due to similar mass peptides: Confirm through fragmentation pattern analysis and comparison with synthetic standards

• Sample degradation during preparation: Minimize by including protease inhibitors and maintaining cold chain

Proper technique optimization has enabled successful identification of authentic Periviscerokinin-1 in multiple fractions from cockroach nervous tissue .

How can inconsistencies in quantification of Periviscerokinin-1 across different studies be reconciled?

To address quantification discrepancies across studies:

• Standardize tissue extraction protocols to ensure complete peptide recovery

• Calibrate quantification methods against common synthetic peptide standards

• Report detailed methodological parameters that might influence quantification

• Consider species-specific and developmental variations in peptide expression

• Account for the potential presence of both oxidized and non-oxidized forms in quantification

• Implement internal standards for each analysis to normalize results across studies

Following these practices helps reconcile the reported concentration of 6.3 pmol in abdominal PSOs and 1.3 pmol in abdominal ganglia with findings from other studies.